Forgettable in the Care of Liver Cirrhosis: the Unseen Culprits of Progression from Bad to Worse

Overview

Journal Prz Gastroenterol

Publisher Termedia

Specialty Gastroenterology

Date 2024 Apr 4

PMID 38571544

Authors

Maha Elsabaawy

Omkosoum Alhaddad

Affiliations

Soon will be listed here.

Abstract

Patients with liver cirrhosis constitute a critically ill and unique population, and their stability relies on a well-coordinated multidisciplinary team with a carefully structured plan. Overlooking any aspect of this plan can expedite disease progression, leading to severe complications. The lack of disease-specific nutritional guidance, the prevalent sedentary lifestyle among patients, and insufficient screening for hepatocellular carcinoma, oesophageal varices, sarcopaenia, minimal hepatic encephalopathy, and diabetes mellitus, along with fibrosis progression and cirrhosis decompensation, can add further complexities. Additionally, devaluing the impact of obesity in triggering liver cirrhosis can be disadvantageous. Prolonged and inappropriate use of proton pump inhibitors also poses a significant challenge with a wide range of complications. These often-unheeded aspects in the care of liver cirrhosis patients represents the unseen culprits of progression from bad to worse and warrant serious consideration.

References

Katz P, Dunbar K, Schnoll-Sussman F, Greer K, Yadlapati R, Spechler S . ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease. Am J Gastroenterol. 2021; 117(1):27-56. PMC: 8754510. DOI: 10.14309/ajg.0000000000001538. View

Bajaj J, Duarte-Rojo A, Xie J, Acharya C, Wade J, Robles C . Minimal Hepatic Encephalopathy and Mild Cognitive Impairment Worsen Quality of Life in Elderly Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2020; 18(13):3008-3016.e2. PMC: 7502426. DOI: 10.1016/j.cgh.2020.03.033. View

Keane J, Elangovan H, Stokes R, Gunton J . Vitamin D and the Liver-Correlation or Cause?. Nutrients. 2018; 10(4). PMC: 5946281. DOI: 10.3390/nu10040496. View

Cortesi P, Conti S, Scalone L, Jaffe A, Ciaccio A, Okolicsanyi S . Health related quality of life in chronic liver diseases. Liver Int. 2020; 40(11):2630-2642. DOI: 10.1111/liv.14647. View

Tokushige K, Ikejima K, Ono M, Eguchi Y, Kamada Y, Itoh Y . Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020. J Gastroenterol. 2021; 56(11):951-963. PMC: 8531062. DOI: 10.1007/s00535-021-01796-x. View

Morando F, Rosi S, Gola E, Nardi M, Piano S, Fasolato S . Adherence to a moderate sodium restriction diet in outpatients with cirrhosis and ascites: a real-life cross-sectional study. Liver Int. 2014; 35(5):1508-15. DOI: 10.1111/liv.12583. View

Lammers W, van Tilburg A, Apers J, Wiebolt J . Liver failure caused by prolonged state of malnutrition following bariatric surgery. World J Hepatol. 2018; 10(3):396-399. PMC: 5871860. DOI: 10.4254/wjh.v10.i3.396. View

Tantai X, Yang L, Wei Z, Xiao C, Chen L, Wang J . Association of proton pump inhibitors with risk of hepatic encephalopathy in advanced liver disease: A meta-analysis. World J Gastroenterol. 2019; 25(21):2683-2698. PMC: 6558434. DOI: 10.3748/wjg.v25.i21.2683. View

Yen F, Lai J, Cheng-Chung Wei J, Chiu L, Hwu C, Hou M . Sulfonylureas may be useful for glycemic management in patients with diabetes and liver cirrhosis. PLoS One. 2020; 15(12):e0243783. PMC: 7735585. DOI: 10.1371/journal.pone.0243783. View

10.

Cabral C, Burns D . Low-protein diets for hepatic encephalopathy debunked: let them eat steak. Nutr Clin Pract. 2011; 26(2):155-9. DOI: 10.1177/0884533611400086. View

11.

Ha N, Montano-Loza A, Carey E, Lin S, Shui A, Huang C . Sarcopenic visceral obesity is associated with increased post-liver transplant mortality in acutely ill patients with cirrhosis. Am J Transplant. 2022; 22(9):2195-2202. PMC: 9427718. DOI: 10.1111/ajt.17079. View

12.

An Y, Li S, Huang X, Chen X, Shan H, Zhang M . The Role of Copper Homeostasis in Brain Disease. Int J Mol Sci. 2022; 23(22). PMC: 9698384. DOI: 10.3390/ijms232213850. View

13.

De Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C . Baveno VII - Renewing consensus in portal hypertension. J Hepatol. 2022; 76(4):959-974. PMC: 11090185. DOI: 10.1016/j.jhep.2021.12.022. View

14.

Khatua B, El-Kurdi B, Singh V . Obesity and pancreatitis. Curr Opin Gastroenterol. 2017; 33(5):374-382. PMC: 6640854. DOI: 10.1097/MOG.0000000000000386. View

15.

Stokes C, Volmer D, Grunhage F, Lammert F . Vitamin D in chronic liver disease. Liver Int. 2013; 33(3):338-52. DOI: 10.1111/liv.12106. View

16.

Bonfrate L, Wang D, Garruti G, Portincasa P . Obesity and the risk and prognosis of gallstone disease and pancreatitis. Best Pract Res Clin Gastroenterol. 2014; 28(4):623-35. DOI: 10.1016/j.bpg.2014.07.013. View

17.

Han W, Zhang H, Han Y, Duan Z . Cognition-tracking-based strategies for diagnosis and treatment of minimal hepatic encephalopathy. Metab Brain Dis. 2020; 35(6):869-881. PMC: 7354280. DOI: 10.1007/s11011-020-00539-w. View

18.

Maras J, Maiwall R, Harsha H, Das S, Hussain M, Kumar C . Dysregulated iron homeostasis is strongly associated with multiorgan failure and early mortality in acute-on-chronic liver failure. Hepatology. 2014; 61(4):1306-20. DOI: 10.1002/hep.27636. View

19.

Reuter B, Shaw J, Hanson J, Tate V, Acharya C, Bajaj J . Nutritional Assessment in Inpatients With Cirrhosis Can Be Improved After Training and Is Associated With Lower Readmissions. Liver Transpl. 2019; 25(12):1790-1799. PMC: 7262968. DOI: 10.1002/lt.25602. View

20.

Finkelmeier F, Kronenberger B, Koberle V, Bojunga J, Zeuzem S, Trojan J . Severe 25-hydroxyvitamin D deficiency identifies a poor prognosis in patients with hepatocellular carcinoma - a prospective cohort study. Aliment Pharmacol Ther. 2014; 39(10):1204-12. DOI: 10.1111/apt.12731. View